ALNY compared with ARGX: revenue, margins and what each company keeps, and the suppliers and customers both name

ALNYAlnylam Pharmaceuticals, Inc.

Mkt capRevenueRevenue

ARGXArgenx SE

Mkt capRevenueRevenue

Compare

ALNYAlnylam Pharmaceuticals, Inc.

ARGXArgenx SE

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALNY 14

BXBlackstonesupplier

REGNRegeneroncustomer

AAgilentsupplier

VEEVVeeva Systemssupplier

10 more · ALNY chain ›

Shared 0

No shared counterparties.

Only ARGX 3

ABBVAbbViecustomer

HALOHalozyme Therapeuticssupplier

—AgomAb Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ALNYAlnylam Pharmaceuticals, Inc.

156.00▼−0.42%· post 156.25

Mkt cap$20.9BRevenue$1.5BQ3 FY26Revenue$3.7BFY25

ARGXArgenx SE

922.85▲+3.14%· post 936.00

ClosedNov 6 '26

Mkt cap$57.4BRevenue—Revenue—

Compare

ClosedNov 6 '26

ALNYAlnylam Pharmaceuticals, Inc.

ARGXArgenx SE

156.00▼−0.42%post 156.25

Price

922.85▲+3.14%post 936.00

$20.9B

Mkt cap

$57.4B

Q3 FY26$1.5B

Revenue

—

FY25$3.7B

Revenue

—

ALNY156.00▼−0.42%vsARGX922.85▲+3.14%ClosedNov 6 '26